Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer

This study has been terminated.
(Insufficient Accrual)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT00003009
First received: November 1, 1999
Last updated: May 20, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2000
  Primary Completion Date: August 2000 (Final data collection date for primary outcome measure)